AGTR2 gene polymorphism is associated with muscle fibre composition, athletic status and aerobic performance

Experimental Physiology

Volumn 99, Issue 8, 2014, Pages 1042-1052

  Mustafina, Leysan J ^a,b   Naumov, Vladimir A ^c   Cieszczyk, Pawel ^d,e   Popov, Daniil V ^f   Lyubaeva, Ekaterina V ^f   Kostryukova, Elena S ^c   Fedotovskaya, Olga N ^g   Druzhevskaya, Anastasiya M ^g   Astratenkova, Irina V ^g   Glotov, Andrey S ^h   Alexeev, Dmitry G ^c   Mustafina, Milyausha M ^b   Egorova, Emiliya S ^b   Maciejewska Karłowska, Agnieszka ^e   Larin, Andrey K ^c   Generozov, Edward V ^c   Nurullin, Ruslan E ^a   JastrzeAbski, Zbigniew ^d   Kulemin, Nickolay A ^c   Ospanova, Elena A ^c   Pavlenko, Alexander V ^c   Sawczuk, Marek ^e   Akimov, Egor B ⁱ   Danilushkina, Anna A ^b   Zmijewski, Piotr ^j   Vinogradova, Olga L ^f   Govorun, Vadim M ^c   Ahmetov, Ildus I ^a,b,c,g   more..

^a Sport and Tourism   (Russian Federation)

^b KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^c FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

^d GDANSK UNIVERSITY OF PHYSICAL EDUCATION AND SPORT   (Poland)

^e UNIVERSITY OF SZCZECIN   (Poland)

^f INSTITUTE OF BIOMEDICAL PROBLEMS   (Russian Federation)

^g St Petersburg Research Institute of Physical Culture   (Russian Federation)

^h ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

ⁱ Centre of Sports Innovative Technologies and Training National Teams   (Russian Federation)

^j INSTITUTE OF SPORT   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; OXYGEN;

ADULT; AEROBIC CAPACITY; ANGIOTENSIN 2 RECEPTOR GENE; ARTICLE; ATHLETIC PERFORMANCE; CAUCASIAN; CONTROLLED STUDY; ENDURANCE SPORT; FAST MUSCLE FIBER; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MUSCLE CELL; NORMAL HUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; SLOW MUSCLE FIBER; VASTUS LATERALIS MUSCLE; YOUNG ADULT; ALLELE; ATHLETE; EXERCISE; GENETICS; METABOLISM; PHYSIOLOGY; SPORT;

ADULT; ALLELES; ATHLETES; EXERCISE; FEMALE; GENOTYPE; HUMANS; MALE; MUSCLE FIBERS, SLOW-TWITCH; OXYGEN CONSUMPTION; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2; SPORTS; YOUNG ADULT;

EID: 84905277848     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.079335     Document Type: Article

References (53)

1. Ahmetov II, Druzhevskaya AM, Lyubaeva EV, Popov DV, Vinogradova OL & Williams AG (2011). The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Exp Physiol 96, 1302-1310.
2. Ahmetov II, Hakimullina AM, Lyubaeva EV, Vinogradova OL & Rogozkin VA (2008). Effect of HIF1A gene polymorphism on human muscle performance. Bull Exp Biol Med 146, 351-353.
3. Ahmetov II, Hakimullina AM, Popov DV, Lyubaeva EV, Missina SS, Vinogradova OL, Williams AG & Rogozkin VA (2009a). Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes. Eur J Appl Physiol 107, 95-103.
4. Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE & Rogozkin VA (2006). PPARα gene variation and physical performance in Russian athletes. Eur J Appl Physiol 97, 103-108.
5. Ahmetov II, Vinogradova OL & Williams AG (2012). Gene polymorphisms and fiber-type composition of human skeletal muscle. Int J Sport Nutr Exerc Metab 22, 292-303.
6. Ahmetov II, Williams AG, Popov DV, Lyubaeva EV, Hakimullina AM, Fedotovskaya ON, Mozhayskaya IA, Vinogradova OL, Astratenkova IV, Montgomery HE & Rogozkin VA (2009b). The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet 126, 751-761.
7. Akhmetov II, Astranenkova IV & Rogozkin VA (2007). Association of PPARD gene polymorphism with human physical performance. Mol Biol (Mosk) 41, 852-857.
8. Akhmetov II, Astratenkova IV, Druzhevskaia AM, Komkova AI, Liubaeva EV, Tarakin PP, Shenkman BS & Rogozkin VA (2006). The association of gene polymorphisms with the muscle fiber type composition. Ross Fiziol Zh Im I M Sechenova 92, 883-888.
9. Akishita M, Horiuchi M, Yamada H, Zhang L, Shirakami G, Tamura K, Ouchi Y & Dzau VJ (2000). Inflammation influences vascular remodeling through AT2 receptor expression and signaling. Physiol Genomics 2, 13-20.
10. Andersen JL, Klitgaard H & Saltin B (1994). Myosin heavy chain isoforms in single fibres from m. vastus lateralis of sprinters: influence of training. Acta Physiol Scand 151, 135-142.
11. Aoki S, Mukae S, Itoh S, Sato R, Nishio K, Ueda H, Iwata T & Katagiri T (2001). Genetic background in patients with acute myocardial infarction. Jpn Heart J 42, 15-28.
12. Baldwin KM & Haddad F (2001). Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol 90, 345-357.
13. Bergh U, Thorstensson A, Sjödin B, Hulten B, Piehl K & Karlsson J (1978). Maximal oxygen uptake and muscle fiber types in trained and untrained humans. Med Sci Sports 10, 151-154.
14. Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA & Barreto-Chaves ML (2010). Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 105, 325-335.
15. Carrillo-Sepúlveda MA, Ceravolo GS, Furstenau CR, Monteiro Pde S, Bruno-Fortes Z, Carvalho MH, Laurindo FR, Tostes RC, Webb RC & Barreto-Chaves MLM (2013). Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism. PLoS One 8, e61982.
16. Chai W, Wang W, Dong Z, Cao W & Liu Z (2011). Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 60, 2939-2946.
17. Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI & Nosikov VV (2002). Further studies of genetic susceptibility to Graves' disease in a Russian population. Med Sci Monit 8, CR180-CR184.
18. Deinum J, van Gool JM, Kofflard MJ, ten Cate FJ & Danser AH (2001). Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension 38, 1278-1281.
19. de Wilde J, Hulshof MF, Boekschoten MV, de Groot P, Smit E & Mariman EC (2010). The embryonic genes Dkk3, Hoxd8, Hoxd9 and Tbx1 identify muscle types in a diet-independent and fiber-type unrelated way. BMC Genomics 11, 176.
20. Eynon N, Nasibulina ES, Banting LK, Cieszczyk P, Maciejewska-Karlowska A, Sawczuk M, Bondareva EA, Shagimardanova RR, Raz M, Sharon Y, Williams AG, Ahmetov II, Lucia A & Birk R (2013). The FTO A/T polymorphism and elite athletic performance: a study involving three groups of European athletes. PLoS One 8, e60570.
21. Fedotovskaya ON, Danilova AA & Akhmetov II (2013). Effect of AMPD1 gene polymorphism on muscle activity in humans. Bull Exp Biol Med 154, 489-491.
22. Frisk-Holmberg M, Essen B, Fredrikson M, Ström G & Wibell L (1983). Muscle fiber composition in relation to blood pressure response to isometric exercise in normotensive and hypertensive patients. Acta Med Scand 213, 21-26.
23. Fry AC, Schilling BK, Staron RS, Hagerman FC, Hikida RS & Thrush JT (2003). Muscle fiber characteristics and performance correlates of male Olympic-style weightlifters. J Strength Cond Res 17, 746-754.
24. Glotov AS, Ivaschenko TE, Obraztsova GI, Nasedkina TV & Baranov VS (2007). Association of permanent arterial hypertension with the renin-angiotensin and kinin-bradykinin system genes in children. Mol Biol (Mosk) 41, 14-21.
25. Higashiura K, Ura N, Takada T, Li Y, Torii T, Togashi N, Takada M, Takizawa H & Shimamoto K (2000). The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats. Am J Hypertens 13, 290-297.
26. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Chen Y, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K & Miki T (2003). Association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens Res 26, 547-552.
27. Johnston AP, Baker J, De Lisio M & Parise G (2011). Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system. J Renin Angiotensin Aldosterone Syst 12, 75-84.
28. Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, Schnohr P & Saltin B (1990). Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 140, 41-54.
29. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Järvinen H, Christin L, Secomb TW & Bogardus C (1987). Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 80, 415-424.
30. Maciejewska A, Sawczuk M, Cieszczyk P, Mozhayskaya IA & Ahmetov II (2012). The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci 30, 101-113.
31. Matsubara H (1998). Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83, 1182-1191.
32. Mitsuishi M, Miyashita K, Muraki A & Itoh H (2009). Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control. Diabetes 58, 710-717.
33. Oganov VS, Vinogradova OL, Dudov NS, Baranov VS, Minenkov AS, Bakulin AV, Novikov VE, Kabitskaya OE, Moskalenko MV, Glotov AS, Glotov OS & Popov DV (2008). Correlation between the bone mass of athletes and biochemical and genetic markers of bone tissue remodeling. Hum Physiol 34, 56-65.
34. Qi JS, Minor LK, Smith C, Hu B, Yang J, Andrade-Gordon P & Damiano B (2005). Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors. Peptides 26, 683-690.
35. Ricoy JR, Encinas AR, Cabello A, Madero S & Arenas J (1998). Histochemical study of the vastus lateralis muscle fibre types of athletes. J Physiol Biochem 54, 41-47.
36. Sawczuk M, Timshina YI, Astratenkova IV, Maciejewska-Karłowska A, Leońska-Duniec A, Ficek K, Mustafina LJ, CieAszczyk P, Klocek T & Ahmetov II (2013). The -9/+9 polymorphism of the bradykinin receptor beta 2 gene and athlete status: a study involving two European cohorts. Hum Biol 85, 743-757.
37. Schiaffino S & Reggiani C (2011). Fiber types in mammalian skeletal muscles. Physiol Rev 91, 1447-1531.
38. Seip RL, Volek JS, Windemuth A, Kocherla M, Fernandez ML, Kraemer WJ & Ruaño G (2008). Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat. Nutr Metab (Lond) 5, 4.
39. Simoneau J-A & Bouchard C (1989). Human variation in skeletal muscle fiber-type proportion and enzyme activities. Am J Physiol Endocrinol Metab 257, E567-E572.
40. Simoneau J-A & Bouchard C (1995). Genetic determinism of fiber type proportion in human skeletal muscle. FASEB J 9, 1091-1095.
41. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT, Ragg KE & Toma K (2000). Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 48, 623-629.
42. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, Cunningham PR, Swanson MS & Houmard JA (2002). Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282, 1191-1196.
43. Theobald J & DiMario JX (2011). Lineage-based primary muscle fiber type diversification independent of MEF2 and NFAT in chick embryos. J Muscle Res Cell Motil 31, 369-381.
44. Vincent B, De Bock K, Ramaekers M, Van den Eede E, Van Leemputte M, Hespel P & Thomis MA (2007). ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics 32, 58-63.
45. Wang G, Padmanabhan S, Wolfarth B, Fuku N, Lucia A, Ahmetov II, Cieszczyk P, Collins M, Eynon N, Klissouras V, Williams A & Pitsiladis Y (2013). Genomics of elite sporting performance: what little we know and necessary advances. Adv Genet 84, 123-149.
46. Warnecke C, Mugrauer P, Sürder D, Erdmann J, Schubert C & Regitz-Zagrosek V (2005). Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. Am J Physiol Regul Integr Comp Physiol 289, R1729-R1735.
47. Wei C, Cardarelli MG, Downing SW & McLaughlin JS (2000). The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes. J Renin Angiotensin Aldosterone Syst 1, 379-384.
48. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R & Williams RS (2001). Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20, 6414-6423.
49. Yang D, Ma S, Tan Y, Li D, Tang B, Zhang X, Sun M & Yang Y (2010). Increased expression of calpain and elevated activity of calcineurin in the myocardium of patients with congestive heart failure. Int J Mol Med 26, 159-164.
50. Zarebska A, Ahmetov II, Sawczyn S, Weiner AS, Kaczmarczyk M, Ficek K, Maciejewska-Karlowska A, Sawczuk M, Leonska-Duniec A, Klocek T, Voronina EN, Boyarskikh UA, Filipenko ML & Cieszczyk P (2014). Association of the MTHFR 1298A>C (rs1801131) polymorphism with speed and strength sports in Russian and Polish athletes. J Sports Sci 32, 375-382.
51. Zawadowska B, Majerczak J, Semik D, Karasinski J, Kolodziejski L, Kilarski WM, Duda K & Zoladz JA (2004). Characteristics of myosin profile in human vastus lateralis muscle in relation to training background. Folia Histochem Cytobiol 42, 181-190.
52. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M & Saku K (2003). The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 63, 139-144.
53. Zheng L, Wang W, Ni J, Li Z & Xiao T (2014). The association of eNOS gene polymorphism with avascular necrosis of femoral head. PLoS One 9, e87583.